Panamera Holdings hires board member Barakat as clinical officer under consulting deal

Panamera Holdings Corp

Entered consulting agreement with First DB Ventures LP at $8,333/month for healthcare consulting.
Board member Christopher Barakat appointed Clinical Business Development Officer to serve under the agreement.
Both the consulting and employment arrangements are month-to-month at-will.
Compensation is $8,333 per month for consulting services.

item 1.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Christopher Barakat

Clinical Business Development Officer

PHCI · Panamera Holdings Corp

Effective: 2022-05-18
Filed: May 24, 2022, 7:59 PM ET

entered into an Employment Contract with Christopher Barakat, a member of our board of directors, to serve in the capacity of a Clinical Business Development Officer

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Christopher Barakat was appointed as Clinical Business Development Officer at Panamera Holdings Corp.

Action: appointed
Role: Clinical Business Development Officer

Exact text from the filing

entered into an Employment Contract with Christopher Barakat, a member of our board of directors, to serve in the capacity of a Clinical Business Development Officer

View on SEC.gov

Panamera Holdings Corp filing history →

Source: SEC EDGAR

accession 0001640334-22-001109

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.